D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.52B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$798M |
| 4 |
Amazon
AMZN
|
+$646M |
| 5 |
Texas Instruments
TXN
|
+$619M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.31B |
| 2 |
Broadcom
AVGO
|
+$1.01B |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$863M |
| 4 |
Western Digital
WDC
|
+$595M |
| 5 |
Meta Platforms (Facebook)
META
|
+$591M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.6% |
| 2 | Consumer Discretionary | 9.12% |
| 3 | Healthcare | 7.62% |
| 4 | Industrials | 7.14% |
| 5 | Financials | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
NextNav
NN
$1.78B
| $6.17M | ﹤0.01% |
370,855
+103,060
| +38% | +$1.46M |
|
2027
CALL
State Street
STT
$50.5B
| $6.17M | ﹤0.01% |
47,800
+37,700
| +373% | +$4.51M |
|
|
COPL
2028
Copley Acquisition Corp
COPL
$247M
| $6.16M | ﹤0.01% |
600,000
| – | – |
|
2029
CALL
Valaris
VAL
$5.3B
| $6.16M | ﹤0.01% |
122,200
+27,400
| +29% | +$1.47M |
|
2030
Merchants Bancorp
MBIN
$2.28B
| $6.14M | ﹤0.01% |
180,308
+34,241
| +23% | +$1.12M |
|
2031
Evergy
EVRG
$19.7B
| $6.13M | ﹤0.01% |
+84,627
| New | +$6.42M |
|
2032
Indivior Pharmaceuticals
INDV
$4.79B
| $6.13M | ﹤0.01% |
170,867
-42,387
| -20% | -$1.29M |
|
|
MACI
2033
Melar Acquisition Corp I
MACI
$236M
| $6.13M | ﹤0.01% |
576,328
| – | – |
|
2034
PUT
NuScale Power
SMR
$2.67B
| $6.12M | ﹤0.01% |
432,100
+325,400
| +305% | +$9.31M |
|
2035
Amkor Technology
AMKR
$15.6B
| $6.11M | ﹤0.01% |
154,786
+35,886
| +30% | +$1.28M |
|
2036
CALL
IAMGOLD
IAG
$8.17B
| $6.1M | ﹤0.01% |
+370,000
| New | +$5.21M |
|
|
CCAQ
2037
Collective Acquisition Corp
CCAQ
$212M
| $6.09M | ﹤0.01% |
598,000
| – | – |
|
2038
Aquestive Therapeutics
AQST
$517M
| $6.08M | ﹤0.01% |
941,197
+915,697
| +3,591% | +$5.71M |
|
2039
PUT
The Mosaic Company
MOS
$7.03B
| $6.08M | ﹤0.01% |
252,200
+67,100
| +36% | +$1.81M |
|
2040
Magnolia Oil & Gas
MGY
$5.04B
| $6.06M | ﹤0.01% |
276,774
+214,897
| +347% | +$4.89M |
|
2041
CALL
Bank of America
BAC
$430B
| $6.06M | ﹤0.01% |
110,100
+98,200
| +825% | +$5.19M |
|
2042
Central Garden & Pet Co Class A
CENTA
$2.4B
| $6.05M | ﹤0.01% |
207,126
-40,091
| -16% | -$1.16M |
|
2043
Tyson Foods
TSN
$20.3B
| $6.04M | ﹤0.01% |
103,050
+35,764
| +53% | +$1.96M |
|
2044
Cogent Communications
CCOI
$549M
| $6.04M | ﹤0.01% |
280,136
-112,993
| -29% | -$3.34M |
|
2045
Fastenal
FAST
$52.2B
| $6.03M | ﹤0.01% |
150,353
-123,554
| -45% | -$5.2M |
|
2046
PUT
Regeneron Pharmaceuticals
REGN
$70.9B
| $6.02M | ﹤0.01% |
7,800
-12,200
| -61% | -$8.29M |
|
|
FRMI
2047
Fermi Inc
FRMI
$3.86B
| $6.01M | ﹤0.01% |
+751,592
| New | +$14.7M |
|
2048
Mesa Laboratories
MLAB
$541M
| $6.01M | ﹤0.01% |
76,565
+43,754
| +133% | +$3.33M |
|
|
RNGT
2049
Range Capital Acquisition Corp II
RNGT
| $6.01M | ﹤0.01% |
+602,083
| New | +$6.02M |
|
2050
Voya Financial
VOYA
$9.04B
| $6.01M | ﹤0.01% |
80,653
+61,514
| +321% | +$4.48M |
|
Similar funds
D.E. Shaw & Co's Q4 2025 Portfolio in Review
As of Q4 2025, D.E. Shaw & Co held 5,141 positions worth $182B, up 3% from $177B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2025 filing shows 639 new, 1,734 increased, 1,574 reduced and 583 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M. The largest sale was Micron Technology, an estimated $1.31B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M.
- D.E. Shaw & Co added most to Advanced Micro Devices in Q4 2025, an estimated $1.52B increase.
- D.E. Shaw & Co's biggest Q4 2025 reduction was Micron Technology, cutting an estimated $1.31B.
- D.E. Shaw & Co fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2025, selling an estimated $499M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $182B portfolio in Q4 2025.
- D.E. Shaw & Co opened 639 new positions and closed 583 in Q4 2025.
- D.E. Shaw & Co's portfolio value rose 3% quarter-over-quarter to $182B.
Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.